New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - nizatidine 150mg;   - capsule - 150 mg - active: nizatidine 150mg   excipient: dimeticone magnesium stearate starch

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - nizatidine 300mg;   - capsule - 300 mg - active: nizatidine 300mg   excipient: carmellose sodium dimeticone povidone purified talc starch

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - methohexital sodium 500mg - solution for injection - 500 mg - active: methohexital sodium 500mg

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - dobutamine hydrochloride 280mg equivalent to 250 mg dobutamine;  ;   - solution for infusion - 250 mg - active: dobutamine hydrochloride 280mg equivalent to 250 mg dobutamine     excipient: sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - erythromycin estolate 360mg equivalent to 250 mg erythromycin base;   - capsule - 250 mg - active: erythromycin estolate 360mg equivalent to 250 mg erythromycin base   excipient: erythrosine gelatin   hydrated silica iron oxide red iron oxide yellow liquid paraffin magnesium stearate opacode purified talc quinoline yellow tekprint black sw-9008 titanium dioxide   water  

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - erythromycin estolate 36 mg/ml equivalent to 25 mg/ml erythromycin base;   - oral suspension - 125 mg/5ml - active: erythromycin estolate 36 mg/ml equivalent to 25 mg/ml erythromycin base   excipient: citric acid monohydrate dimeticone dispersible cellulose imitation orange juice methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium calcium edetate sodium chloride sodium citrate dihydrate sodium laurilsulfate sucrose sunset yellow fcf

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - erythromycin estolate 72 mg/ml equivalent to 50 mg/ml erythromycin base;   - oral suspension - 250 mg/5ml - active: erythromycin estolate 72 mg/ml equivalent to 50 mg/ml erythromycin base   excipient: citric acid monohydrate dimeticone dispersible cellulose imitation 0range juice methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium calcium edetate sodium chloride sodium citrate dihydrate sodium laurilsulfate sucrose sunset yellow fcf

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - erythromycin estolate 360mg equivalent to 250 mg erythromycin base;   - tablet - 250 mg - active: erythromycin estolate 360mg equivalent to 250 mg erythromycin base  

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - erythromycin estolate 720mg equivalent to 500 mg erythromycin base;  ;   - tablet - 500 mg - active: erythromycin estolate 720mg equivalent to 500 mg erythromycin base     excipient: erythrosine   glycerol hyprolose hypromellose magnesium stearate methanol methylated spirits methylene chloride purified water quinoline yellow starch sunset yellow fcf titanium dioxide trichloroethane white beeswax

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - glucagon hydrochloride 1mg equivalent to 1 unit, (bovine, north america) - solution for injection - 1 mg - active: glucagon hydrochloride 1mg equivalent to 1 unit, (bovine, north america) excipient: lactose monohydrate glycerol phenol water for injection